Sage Journals: Discover world-class research

Open access

Research article

First published 2022

Buprenorphine Waiver Attitudes Among Primary Care Providers

Benjamin Lai, Ivana Croghan, Jon O. Ebbert

Journal of Primary Care & Community Health

Retricted access

Research article

First published 2025-7

Examining the Impact of Eliminating the X Waiver on Buprenorphine Dispensation in 63 Counties in Pennsylvania

Rebecca C. Bilden, Mark S. Roberts, Bradley D. Stein [...]

Substance Use & Addiction Journal

Open access

Research article

First published 2026

Assessing the Initial Impact of X-Waiver Elimination on Buprenorphine Prescribing for Opioid Use Disorder

Wen-Jan Tuan, Sujeong Park, Shazib Altaf [...]

Substance Use & Addiction Journal

Retricted access

Article commentary

First published 2023-7

Will the End of the X-Waiver Expand Access to Buprenorphine Treatment? Achieving the Full Potential of the 2023 Consolidated Appropriations Act

Brendan Saloner, Barbara Andraka-Christou, Bradley D. Stein [...]

Substance Use & Addiction Journal

Retricted access

Research article

First published 2022-12

Accuracy of Publicly-Listed Locator Information for Buprenorphine Waivered Practitioners and Opioid Treatment Programs in the US,2020

Rachel E. Barenie, Brian L. Winbigler, R. Eric Heidel [...]

Substance Use & Addiction Journal

Retricted access

Research article

First published 2022-12

Differences in Perceived Clinical Knowledge Uptake among Health Profession Students and Licensed Clinicians Receiving Buprenorphine Waiver Training in Oregon

Jonathan L. Robbins, Kathryn Bonuck, Philippe Thuillier [...]

Substance Use & Addiction Journal

Retricted access

Article commentary

First published 2021-4

Article Commentary: It Will End in Tiers: A Strategy to Include “Dabblers” in the Buprenorphine Workforce after the X-Waiver

Brendan Saloner, Barbara Andraka Christou, Adam J. Gordon [...]

Substance Use & Addiction Journal

Retricted access

Brief report

First published 2022-12

Trends in Buprenorphine-Waivered Providers in Medicaid Expansion and Non-Expansion States by Their Public Listing Status

Maria X. Sanmartin, Mir M. Ali, Debra S. Dwyer

Substance Use & Addiction Journal

Retricted access

Research article

First published 2022-12

A Bridge Too Far? Distance to Waivered Physicians and Utilization of Buprenorphine Treatment for Opioid use Disorder in West Virginia Medicaid

Brendan Saloner, Rachel K. Landis, Ritujith Jayakrishnan [...]

Substance Use & Addiction Journal

Retricted access

Research article

First published 2020-4

Adoption of the 275-Patient Buprenorphine Treatment Waiver for Treating Opioid Use Disorder: A State-Level Longitudinal Analysis

Hannah K. Knudsen, Lewei (Allison) Lin, Michelle R. Lofwall

Substance Use & Addiction Journal

Search results